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Mixed medullary-follicular carcinoma (MMFC) of thyroid is an
extremely rare tumor, characterized by coexistence of morpho-
logical and immunohistochemical features of both medullary
carcinoma and follicular (or papillary) carcinoma. We herein
present fine needle aspiration (FNA) findings of a histology-con-
firmed MMFC along with a review of literature. The patient was
a 64-year-old woman who had a history of Hashimoto’s thyroid-
itis and presented with enlargement of preexisting right thyroid
nodule. An US-guided FNA of the thyroid nodule was performed
and conventional smears were prepared. A cytologic diagnosis
of ‘‘positive for malignancy, consistent with medullary thyroid
carcinoma (MTC)’’ was rendered based on the presence of fea-
tures characteristic for MTC, and the absence of components of
follicular neoplasm (adenoma and carcinoma) or papillary car-
cinoma. However, microscopic examination of the follow-up
total thyroidectomy specimen with the aid of immunocytochemi-
cal study detected minor portion of follicular carcinoma in addi-
tion to MTC. A histologic diagnosis of MMFC was then estab-
lished. While specific identification of MMFC by FNA may be
difficult, it should be emphasized that adequate sampling in
conjunction with the proper immunostaining panel could have
highlighted the different aspects of the mixed tumor. Diagn.
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Unlike papillary thyroid carcinoma, mixed medullary-fol-
licular carcinoma (MMFC) of thyroid is an extremely rare
tumor which represents less than 0.15% of all thyroid
tumors. The majority of MMFC occurs in a sporadic form
and the remainder of cases occurs as a component of he-
reditary syndromes such as multiple endocrine neoplasia
(MEN) type 2. Pathologically, the tumor is characterized
by coexistence of morphological and immunohistochemi-
cal features of both medullary carcinoma and follicular
(or papillary) carcinoma.1 There are many theories regard-
ing histogenesis of MMFC. As previously reported, muta-
tions in the RET that is similar to or different from those
detected in sprodic medullary thyroid carcinoma have
been detected in a limited number of cases of MMFC.2–4
We herein present fine-needle aspiration (FNA) findings
along with histologic features, as well as results of clini-
cal laboratory test including RET mutations in a patient
with a histologic diagnosis of MMFC. The challenges
associated with the FNA cytologic diagnosis of MMFC
will be discussed.
Case Reports
A 64-year-old woman with a history of Hashimoto’s thy-
roiditis presented with a chief complaint of enlargement of
pre-existing right thyroid nodule accompanied by difficulty
swallowing. The patient noted a right thyroid nodule and
underwent a FNA procedure five years ago. The diagnosis
of Hashimoto’s thyroiditis was established at that time. Her
most recent physical examination revealed that the enlarged
nodule measured 2.5 cm in the greatest dimension. A
repeated US-guided FNA was then performed at the outside
institution and only conventional smears were prepared
during the procedure. The cytological differential diagnoses
included neoplasm (Hurthle cell neoplasm versus MTC)
and less likely Hashimoto thyroiditis. The patient was then
referred to our institution for a definitive diagnosis.
The conventional smears prepared from the FNA of the
right thyroid nodule at the outside institution (Fig. 1)
revealed moderate cellularity with the cells arranged in a
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dispersed pattern. There are predominantly plasmacytoid
cells admixed with minor portion of scattered polygonal
cells and spindle cells. The plasmacytoid cells show well-
or ill-defined cytoplasmic borders, granular cytoplasm,
and eccentrically located nuclei. Occasional bi- or multi-
nucleation and rare giant nuclei are seen. Chromatin has
classic salt and pepper pattern. The background is clean
without amorphous acellular material (amyloid) identified.
Feature of follicular neoplasm or papillary thyroid carci-
noma are not seen. Based upon these findings, a cytologic
diagnosis of ‘‘positive for malignancy, consistent with
MTC’’ was rendered. For further confirmation, the
patient’s serum level of calcitonin was then tested and the
value is 5,741 pg/ml (normal < 12 pg/ml). A total thy-
roidectomy with central lymph node dissection was subse-
quently performed. The serum calcitonin level dropped to
7.6 pg/ml following the surgery.
Gross examination of the surgical specimen revealed a
2.5 3 1.8 3 1.5 cm well-circumscribed mass in the right
thyroid. The mass did not invade surrounding capsule.
Microscopically, the tumor exhibited predominantly solid
growth pattern. In addition, there were tumor cells
arranged in follicles that were scattered throughout the
Fig. 2. Histology of follow-up total thyrodectomy and immunostaining
profile. A: H&E 3200; B: calcitonin, 3200; C: thyroglobulin, 3200.
[Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
Fig. 1. Conventional smears prepared from the FNA of right thyroid
nodule. A: Diff-Quik 3200; B: Papanicolaou 3600. [Color figure can
be viewed in the online issue, which is available at wileyonlinelibrary.
com.]
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tumor. Immunostaining revealed that the tumor cells were
diffusely positive for calcitonin, CEA, and chromogranin.
Further, there are scattered follicles that stained positively
with antibody against thyroglobulin (Fig. 2). The histolog-
ical findings in correlation with the immuonprofile, sup-
port a diagnosis of MMFC.
Germline RET proto-oncogene mutation in exons (10,
11, 13, 14, 15, and 16) was tested using blood sample
and mutations were not detected. In addition, results of
blood testing for pheochromocytoma (metanephrines) and
hyperparathyroidism (intact parathyroid hormone and cal-
cium) were within the normal range. These findings in
conjunction with the patient’s negative family history and
late onset of the symptoms suggest a likelihood of spo-
radic MMFC.
Discussion
The patient reported herein was referred to our institution
for a definitive diagnosis. The major differential cytologic
diagnoses included medullary thyroid carcinoma, Hurthle
cell neoplasm and Hashimoto’s thyroiditis. The secondary
cytologic review revealed features characteric for MTC.
These features included but are not limited to dispersed,
pleomorphic cells (i.e., plasmacytoid, polygonal, spindle),
granular cytoplasm, and classic salt and pepper chromatin.
However, it is not uncommon that Hurthle cell neoplasm
is mistyped as MTC due to their morphologic resem-
blance. It has been indicated that the presence of dense
cytoplasm and prominent or cherry-red nucleoli favors a
diagnosis of Hurthle cell neoplasm.5,6 The misinterpreta-
tion of MTC as Hashimoto’s thyroiditis has also been pre-
viously reported.7 On the basis of our experience, scant
lymphocytes may appear in smears of non-lymphocytic
(Hashimoto’s) thyroiditis and the lymphocyts may come
from peripheral blood during FNA procedure. The lack of
moderate to large amount of polymorphous population of
lymphocytes in the background, in addition to the absence
of follicular/Hurthle cells, makes the diagnosis of Hashi-
moto’s thyroiditis very unlikely. It is noteworthy to men-
tion that MTC may mimic not only any of the primary
thyroid neoplasms, but also metastatic neoplasms. Exten-
sive discussion of differential diagnoses of medullary thy-
roid carcinoma is beyond the scope of this short commu-
nication. Briefly, it is infrequent that MTC may exhibit
syncytial, follicular or papillary configuration while vari-
ous portion of dispersed pleomorphic cells may be visual-
ized in follicular neoplasm or papillary thyroid carcinoma;
intranuclear inclusions may be seen in both MTC and
papillary thyroid carcinoma; Giant, bizarre nuclei seen in
anaplastic carcinoma may be occasionally seen in MTC.
Further, melanoma, plasmacytoma, spindle cell neoplasm
of soft tissue, as well as neoplasms with neuroendocrine
differentiation may be mistyped as MTC.8 When in doubt,
ancillary studies such as serum calcitonin level and/or
immunocytohemical (ICC) panel including calcitonin,
CEA, chromogranin and thyroglobulin should be used as
a vital adjunct in FNA diagnosis of MTC. Most patients
have an increased serum calcitonin level of > 10 pg/ml.
MTC should stain positive for calcitonin, CEA, and chro-
mogranin; negative for thyroglobulin.9 The patient
reported herein had a marked elevated serum level of cal-
citonin prior to the total thyroidectomy and the level
dropped into normal range after the surgery. ICC study
was not performed at the time of cytologic diagnosis as
the cell block was not available.
To our surprise, microscopic examination of the follow-
up total thyroidectomy specimen with the aid of immuno-
histochemical studies not only confirmed the FNA cyto-
logic diagnosis of MTC but also identified minor portion of
tumor cells arranged in follicles that were scattered
throughout the tumor and stained positively with antibody
against thyroglobulin. A histologic diagnosis of MMFC
instead of MTC was thus established. As previously men-
tioned, MMFC is an extremely rare tumor of thyroid. A few
case reports of FNA of MMFC are found in the English lit-
erature. Of these cases, none was correctly typed as MMFC
by FNA cytologic evaluation.10–13 With regard to the case
reported herein, we re-reviewed the cytologic material
received form the outside institution along with the speci-
men of total thyroidectomy which was performed in our
institution. However, the conventional smears showed
MTC only and components of follicular neoplasm were not
identified. It appears that sampling issue is the most likely
contributor to the mistyping. Almost all MMFC consist pre-
dominately of MTC and minor portion of follicular carci-
noma that is distributed in a scattered fashion. Obtaining a
specimen composed of both MTC and follicular carcinoma
components relies on adequate sampling. There is no con-
sensus supporting a minimum number of FNA passes
required to obtain adequate samples. In our institution, four
to six passes per thyroid nodules has been recommended.14
Assuming an ideal cytology sample composed of cells of
both MTC and follicular cells was obtained, it is still very
difficult using cytomorphologic assessment alone to make a
distinction among MMFC, follicular variant of medullary
carcinoma and medullary carcinoma with entrapped fol-
licles.15 ICC may serve as a valuable adjunct in such a sce-
nario. Thus, additional material should be collected for cell
block in an appropriate clinical context that MTC is sus-
pected during the immediate cytologic assessment. It is
speculated that a proper ICC panel consisting of antibodies
for thyroglobulin, calcitonin, CEA, as well as synaptophy-
sin and/or chromogranin could have highlighted different
cell populations.
The majority of MMFC occurs in a sporadic form and
rare cases occur as a component of hereditary syndromes
such as MEN type 2. Mutations in the RET that is similar
to or different from those detected in sprodic medullary
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thyroid carcinoma have been detected in a limited number
of cases of MMFC.2–4 In our patient, the lack of germline
RET proto-oncogene mutation, a negative family history
and late onset of the symptoms suggest a likelihood of
sporadic MMFC. On the basis of the previously published
single case reports, it remains controversial whether
MMFC and MTC behave differently in terms of clinical
course and management, as well as response to the con-
ventional therapy.11,16,17 A possible efficacy of adjuvant
radioiodine on the follicular component of MMFC has
been suggested though the treatment is mostly surgical
intervention which is driven by the medullary component
of this mixed tumor.18
In summary, while specific identification of MMFC by
FNA may be difficult, it should be emphasized that
adequate sampling in conjunction with the proper immu-
nostaining panel could have highlighted the different
aspects of the mixed tumor.
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